Journal Article

IDH mutation impairs histone demethylation and results in a block to cell differentiation

Kapoor, Gurpreet S., Chan, Timothy A., Abdel-Wahab, Omar, Figueroa, Maria E., Edwards, Christopher R., Mellinghoff, Ingo K., Berger, Shelley L., Khanin, Raya, Ward, Patrick S., Melnick, Ari, Levine, Ross L., Wellen, Kathryn E., Lu, Chao, Rohle, Dan, Turcan, Sevin, O’Rourke, Donald M., Thompson, Craig B.

2012

Overview

Cancer-associated IDH mutants that produce 2-hydroxyglutarate are shown to prevent the histone demethylation that is required for lineage-specific progenitor cells to differentiate into terminally differentiated cells. Cancer induction by isocitrate dehydrogenase mutation Mutations in the isocitrate dehydrogenase genes IDH1 and IDH2 have been identified in gliomas, the most common form of brain tumour, and in other cancers including leukaemias. The mutated enzymes produce 2-hydroxyglutarate (2HG), which is a potential oncometabolite. Three papers in this issue of Nature examine the mechanisms through which IDH mutations promote cancers. Lu et al . show that 2HG-producing IDH mutants can prevent the histone demethylation that is required for progenitor cells to differentiate, potentially contributing to tumour-cell accumulation. Turcan et al . show that IDH1 mutation in primary human astrocytes induces DNA hypermethylation and reshapes the methylome to resemble that of the CIMP phenotype, a common feature of gliomas and other solid tumours. Koivunen et al . show that the ( R )-enantiomer of 2HG (but not the ( S )-enantiomer) can stimulate the activity of the EGLN prolyl 4-hydroxylases, leading to diminished levels of hypoxia-inducible factor (HIF), which in turn can enhance cell proliferation. These papers establish a framework for understanding gliomagenesis and highlight the interplay between genomic and epigenomic changes in human cancers. Recurrent mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 have been identified in gliomas, acute myeloid leukaemias (AML) and chondrosarcomas, and share a novel enzymatic property of producing 2-hydroxyglutarate (2HG) from α-ketoglutarate 1 , 2 , 3 , 4 , 5 , 6 . Here we report that 2HG-producing IDH mutants can prevent the histone demethylation that is required for lineage-specific progenitor cells to differentiate into terminally differentiated cells. In tumour samples from glioma patients, IDH mutations were associated with a distinct gene expression profile enriched for genes expressed in neural progenitor cells, and this was associated with increased histone methylation. To test whether the ability of IDH mutants to promote histone methylation contributes to a block in cell differentiation in non-transformed cells, we tested the effect of neomorphic IDH mutants on adipocyte differentiation in vitro . Introduction of either mutant IDH or cell-permeable 2HG was associated with repression of the inducible expression of lineage-specific differentiation genes and a block to differentiation. This correlated with a significant increase in repressive histone methylation marks without observable changes in promoter DNA methylation. Gliomas were found to have elevated levels of similar histone repressive marks. Stable transfection of a 2HG-producing mutant IDH into immortalized astrocytes resulted in progressive accumulation of histone methylation. Of the marks examined, increased H3K9 methylation reproducibly preceded a rise in DNA methylation as cells were passaged in culture. Furthermore, we found that the 2HG-inhibitable H3K9 demethylase KDM4C was induced during adipocyte differentiation, and that RNA-interference suppression of KDM4C was sufficient to block differentiation. Together these data demonstrate that 2HG can inhibit histone demethylation and that inhibition of histone demethylation can be sufficient to block the differentiation of non-transformed cells.

• Publisher: Nature Publishing Group UK,Nature Publishing Group
• Subject: 3T3-L1 Cells / 631/208/737 / 631/337/100/2285 / 631/337/176/1988 / 692/699/67 / Adipocytes - cytology / Adipocytes - drug effects / Adipocytes - metabolism / Animals / Astrocytes - cytology / Astrocytes - drug effects / Biological and medical sciences / Brain cancer / Cell differentiation / Cell Differentiation - drug effects / Cell Differentiation - genetics / Cell differentiation, maturation, development, hematopoiesis / Cell Line, Tumor / Cell Lineage - genetics / Cell physiology / Deoxyribonucleic acid / DNA / DNA methylation / DNA Methylation - drug effects / Enzyme Induction - drug effects / Fundamental and applied biological sciences. Psychology / Gene Expression Regulation - drug effects / Genetics / Glioma - enzymology / Glioma - genetics / Glioma - pathology / Glutarates - metabolism / Glutarates - pharmacology / HEK293 Cells / Histones - metabolism / Humanities and Social Sciences / Humans / Isocitrate Dehydrogenase - antagonists & inhibitors / Isocitrate Dehydrogenase - genetics / Isocitrate Dehydrogenase - metabolism / Jumonji Domain-Containing Histone Demethylases - antagonists & inhibitors / Jumonji Domain-Containing Histone Demethylases - deficiency / Jumonji Domain-Containing Histone Demethylases - genetics / Jumonji Domain-Containing Histone Demethylases - metabolism / letter / Methylation - drug effects / Mice / Molecular and cellular biology / multidisciplinary / Mutants / Mutation / Mutation - genetics / Neural Stem Cells - metabolism / Promoter Regions, Genetic - genetics / Science / Science (multidisciplinary) / Statistical analysis